Recent advances in molecular genetics, together with further understanding of cerebral biochemical metabolism affecting the white matter, when taken together with the information provided by MRI and MRS, provide new insights into the inherited white matter diseases.
KayeEM: Update on genetic disorders affecting white matter. Pediatr Neurol24: 11–24, 2001.
2.
SasakiMSakuragawaNTakashimaS: MRI and CT findings in Krabbe's disease. Pediatr Neurol7: 283–8, 1991.
3.
GuoACPetrellaJRKurtzbergJ: Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: Initial experience. Radiology218: 809–815, 2001.
HagbergBKollbergHSouranderP: Infantile globoid cell leukodystrophy (Krabbe's disease). A clinical and genetic study of 32 Swedish cases 1953–1967. Neuropadiatrie1: 74–88, 1969.
9.
ZlotogoraJRegevRZeiglerM: Krabbe disese: Increased incidence in a highly inbred community. Am J Med Genet21: 765–770, 1985.
10.
KrivitWShapiroEGPetersC: Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med338: 1119–26, 1998.
van der VoornJPPouwelsPJKamphorstW: Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders. Am J Neuroradiol26: 442–446, 2005.
14.
GieselmannVMatznerUHessB: Metachromatic leukodystrophy: Molecular genetics and an animal model. J Inherit Metab Dis21: 564–74, 1998.
15.
GortLCollMJChabasA: Identification of 12 novel mutations and two new polymorphisms in the arylsulfatase A gene: Haplotype and genotype-phenotype correlation studies in Spanish metachromatic leukodystrophy patients. Hum Mutat14: 240–8, 1999.
16.
HarveyJSCareyWFMorrisCP: Importance of the glycosylation and polyadenylation variants in metachromatic leukodystrophy pseudodeficiency phenotype. Hum Mol Genet7: 1215–9, 1998.
IgarashiMSchaumburgHHPowersJ: Fatty acid abnormality in adrenoleukodystrophy. J Neurochem26: 851–60, 1976.
19.
YamadaTTaniwakiTShinnohN: Adrenoleukodystrophy protein enhances association of very long-chain acyl-coenzyme A synthetase with the peroxisome. Neurology52: 614–6, 1999.
NaiduSThedaCMoserHW: Peroxisomal disorders. In: SwaimanKFAshwalS, eds. Pediatric neurology: Principles and practice, vol. 1. St. Louis, Missouri: Mosby1999. 510: 29.
22.
WillardHRordanJ: Assignment of the gene for myelin proteolipid protein to the X chromosome: Implications for X-linked myelin disorders. Science230: 940–2, 1985.
23.
GowALazzariniRA: A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet13: 422–8, 1996.
24.
Saugier-VeberPMunnichABonneauD: X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet6: 257–62, 1994.
25.
KendallBE: Inborn errors and demyelination: MRI and the diagnosis of white matter disease. J Inherit Metab Dis16: 771–86, 1993.
26.
PizziniFFatemiASBarkerPB: Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease. Am J Neuroradiol24: 1683–1689, 2003.
GrippKWZimmermanRAWangZJ: Imaging studies in a unique familial dysmyelinating disorder. Am J Neuroradiol19: 1368–1372, 1998.
29.
JansonCMcPheeSBilaniukL: Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Human Gene Therapy13: 1391–1412, 2002.
30.
LeiteCCReedUCOtaduyMC: Congenital muscular dystrophy with merosin deficiency: 1H MR spectroscopy and diffusion-weighted MR imaging. Radiology235: 190–196, 2005.
31.
HillaireDLeclercAFaureS: Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet3: 1657–61, 1994.
32.
VillanovaMMalandriniATotiP: Localization of merosin in the normal human brain: Implications for congenital muscular dystrophy with merosin deficiency. J Submicrose Cytol Pathol28: 1–4, 1996.
Van der KnaapMSNaiduSBreiterSN: Alexander disease: Diagnosis with MR imaging. Am J Neuroradiol22: 541–552, 2001.
35.
JohnsonABPatelNChiuF-C: High molecular weight, GFAP aggregates in Alexander's disease. J Neuropathol Exp Neurol57: 483, 1998.
36.
LiRMessingAGoldmanJE: GFAP mutations in Alexander disease. Int J Dev Neurosci20: 259–268, 2002.
37.
RodriguezDGauthierFBertiniE: Infantile Alexander disease: Spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet69: 1134–1140, 2001.
38.
BrockmannKDechentPMeinsM: Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol250: 300–306, 2003.
